|
POLG expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.770800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.545600E-01 |
| Normal-vs-Stage2 |
2.728000E-01 |
| Normal-vs-Stage3 |
6.117800E-01 |
| Normal-vs-Stage4 |
3.135800E-01 |
| Stage1-vs-Stage2 |
1.980990E-01 |
| Stage1-vs-Stage3 |
4.644800E-01 |
| Stage1-vs-Stage4 |
3.343800E-01 |
| Stage2-vs-Stage3 |
6.510200E-01 |
| Stage2-vs-Stage4 |
9.320200E-02 |
| Stage3-vs-Stage4 |
1.807200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.848600E-01 |
| Normal-vs-AfricanAmerican |
6.437600E-01 |
| Normal-vs-Asian |
7.137900E-03 |
| Caucasian-vs-AfricanAmerican |
9.060400E-01 |
| Caucasian-vs-Asian |
6.596300E-02 |
| AfricanAmerican-vs-Asian |
3.875800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.963200E-01 |
| Normal-vs-Female |
2.313400E-01 |
| Male-vs-Female |
3.022400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.394000E-01 |
| Normal-vs-Extreme_Weight |
7.779600E-01 |
| Normal-vs-Obese |
1.340620E-01 |
| Normal-vs-Extreme_Obese |
3.425000E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.911400E-01 |
| Normal_Weight-vs-Obese |
1.627180E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.151600E-01 |
| Extreme_Weight-vs-Obese |
7.404100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.562800E-01 |
| Obese-vs-Extreme_Obese |
1.801210E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.879200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.451800E-01 |
| Normal-vs-Age(61-80Yrs) |
9.423800E-01 |
| Normal-vs-Age(81-100Yrs) |
3.694600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.584800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.434400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.053000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.164800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.498600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.505000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.289000E-01 |
| Normal-VS-Type2 PRCC |
7.956600E-01 |
| Normal-VS-KIRP CIMP |
3.481200E-01 |
| Normal-VS-Unclassified PRCC |
2.832200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.425600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.632200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.832400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.085200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.308600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.278800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.541600E-01 |
| Normal-vs-N1 |
7.365000E-01 |
| Normal-vs-N2 |
6.263400E-01 |
| N0-vs-N1 |
9.493600E-01 |
| N0-vs-N2 |
6.633000E-01 |
| N1-vs-N2 |
7.026800E-01 |
|
|
